发明名称 |
USE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS, ESPECIALLY TELMISARTAN, IN ORDER TO INCREASE INSULIN SENSITIVITY |
摘要 |
<p>The use of the angiotensin II receptor antagonist telmisartan (I) (or its salt) and the 3-hydroxy-2-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor simvastatin (II) is claimed in the production of medicaments (A) for the treatment or prophylaxis of cardiovascular, cardiopulmonary or renal diseases. Independent claims are included for corresponding treatment methods and pharmaceutical compositions. ACTIVITY : Cardiant; Vasotropic; Hepatotropic; Hypotensive; Antilipemic; Antiarteriosclerotic; Antiasthmatic; Antiinflammatory; Antidiabetic; Cerebroprotective; Antianginal; Cytostatic; Antibacterial; Immunosuppressive; Vulnerary; Osteopathic; Neuroprotective; Nootropic. MECHANISM OF ACTION : Angiotensin II receptor antagonist; HMG-CoA reductase inhibitor; Peroxisome proliferator activated receptor-gamma (PPAR-gamma ) regulating gene expression inducer; Matrix metalloproteinase MMP-9 expression controller; Cytokine CD40L antagonist.</p> |
申请公布号 |
SI1651213(T1) |
申请公布日期 |
2010.01.29 |
申请号 |
SI20040031301T |
申请日期 |
2004.07.24 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
KAUSCHKE STEFAN;MARK MICHAEL;KINTSCHER ULRICH;SCHUPP MICHAEL;UNGER THOMAS |
分类号 |
A61K31/401;A61K31/416;A61K31/4184;A61K45/00;A61K45/06;A61P3/10;A61P5/50;A61P9/12 |
主分类号 |
A61K31/401 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|